NCT04785196 2025-02-26APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid TumorsAscentage Pharma Group Inc.Phase 1/2 Recruiting95 enrolled
NCT03474640 2024-11-22Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Completed184 enrolled 20 charts
NCT05955105 2024-05-21A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesInnolake BiopharmPhase 1/2 Recruiting200 enrolled